Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Latest News about NVS

Recent news which mentions NVS

< Previous 1 2
...
10 11 12 13 14 15 16 17 18
...
27 28 Next >
Biotech stocks could soon get a M&A boost. Here are 3 likely takeover plays.
Tickers ABBV ALNY AMGN ARGX
Tags MRK GILD IBB
From MarketWatch
Looking At Novartis's Recent Unusual Options Activity
Tickers NVS
Tags Market News NVS BZI/UOA
From Benzinga
Avrobio Stock Jumps On Sale Of Gene Therapy Program To Novartis
Tickers AVRO NVS
Tags Benzinga Penny Stocks Market News
From Benzinga
Avrobio Offloads Gene Therapy Program For Rare Genetic Disorder To Novartis
Tickers AVRO NVS
Tags Trading Ideas News Movers
From Benzinga
Immix Biopharma's Subsidiary Says Investigational CAR T Therapy Shows 100% Response Rate In Amyloidosis
Tickers BGNE IMMX JNJ NVS
Tags General Benzinga Briefs
From Benzinga
Why Is AVROBIO (AVRO) Stock Up 83% Today?
Tickers AVRO GHL MULN NVS
Tags NVS MULN Market News
From InvestorPlace
You can’t rely on indexes to pick international stocks, this 5-star fund manager says. Here are 3 of his top selections.
Tickers BRK-B CHKP HDB NVS
Tags KR:005930 JP:7974 UK:TSCO
From MarketWatch
Royalty Pharma Reaffirms FY23 Guidance Post Mixed Q1 Performance
Tickers AZN BIIB KRTX NVS
Tags Earnings AZN Health Care
From Benzinga
What's Going On With Immix Biopharma Stock Today
Tickers BGNE IMMX MRK NVS
Tags General MRK why it's moving
From Benzinga
Amgen vs. Sandoz: Legal Battle Erupts Over Bone-Strengthening Drug Patents
Tickers AMGN NVS
Tags NVS Health Care Market News
From Benzinga
Johnson & Johnson Ignites CAR-T Ambitions With Licensing Pact With Cellular Biomedicine
Tickers GILD JNJ LEGN NVS
Tags GILD General Contracts
From Benzinga
Is This Big Pharma Stock a Buy for Dividend Investors?
Tickers NVS
Tags Market News Recent Press Releases NVS
From Motley Fool
Rare Blood Disorder Treatment Breakthrough: Novartis' Candidate Improves Hemoglobin To Near-Normal Levels
Tickers NVS
Tags Large Cap Benzinga General
From Benzinga
After Q1 Review, Novartis Narrows R&D Pipeline To Prioritize High-Value Transformative Medicines
Tickers NVS
Tags Earnings News Market News
From Benzinga
3 Top Biotech Stocks Defying the Bear Market
Tickers BGNE BIIB LLY NVS
Tags Market News LLY NVS
From Motley Fool
Why Novartis Stock Is Trading Higher Today
Tickers NVS
Tags NVS why it's moving Market News
From Benzinga
Novartis raises 2023 view, after posting higher profit and sales
Tickers NVS
Tags CH:NOVN NVS
From MarketWatch
Earnings Preview: Novartis
Tickers NVS
Tags NVS Benzinga Market News
From Benzinga
Actinium Announces Positive Phase 3 Trial Results, NCI CRADA For AML Drug Candidates – Could They Become New Standards Of Care For This Deadly Disease?
Tickers KURA NVS PFE SNDX
Tags General Benzinga Biotech
From Benzinga
Novartis Says Relapsing Multiple Sclerosis Patients Remained Free From Disease Progression For Up Five Years With Kesimpta Treatment
Tickers NVS
Tags News Market News Health Care
From Benzinga
Why Shares of Legend Biotech Jumped Wednesday
Tickers BMY JNJ LEGN NVS
Tags NVS Recent Press Releases Market News
From Motley Fool
New York Rep. Daniel Goldman Bought Over $50K Worth of Novartis Stock: Here's What You Should Know
Tickers NVS
Tags Government Benzinga General
From Benzinga
2 Best Biotech Stocks to Buy for the Long Haul
Tickers JNJ NVS
Tags NVS Recent Press Releases Market News
From Motley Fool
7 Sorry Pharma Stocks to Sell in April Before It’s Too Late
Tickers ALLR BIIB BMY CLOV
Tags BMY SGMO VYNE
From InvestorPlace
Relay Therapeutics' Stock Price Premium Vs Peers Is Justified By Its Platform Technology, Analyst Says
Tickers NVS RLAY
Tags Price Target Analyst Ratings General
From Benzinga
Novartis Earnings Conference Call Is Coming Up, Here's What You Need To Know
Tickers NVS
Tags Earnings NVS Benzinga
From Benzinga
Alzheimer's Disease Largely Remains A Mystery, With A Lack Of Highly Effective Treatments — Could Regulatory T-Cells (Tregs) Be The Answer?
Tickers COYA LLY NVS
Tags Coya Therapeutics Benzinga General
From Benzinga
Emergent BioSolutions Soars: Analyst Upgrades Stock With Near 100% Upside After FDA's Positive Move
Tickers AMPH AMRX EBS NVS
Tags Health Care AMRX Small Cap
From Benzinga
Cryoport Supports Clinical Trials And Commercial Therapies Across The High-Growth BioTech Industry: Is Its Current Stock Price An Opportunity?
Tickers BX CRSP CYRX GILD
Tags General GILD Partner Content
From Benzinga
6 Questions With Rocket Pharma's CEO On World Health Day: How The Biotech Is 'Changing The Narrative'
Tickers LLY NVS RCKT
Tags News Market News NVS
From Benzinga
< Previous 1 2
...
10 11 12 13 14 15 16 17 18
...
27 28 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.